EBR Systems (EBRCZ) EBITDA Margin (2025 - 2026)
EBR Systems (EBRCZ) posted EBITDA Margin of 684.67% for Q1 2026, up 51.83% sequentially from 1421.36% in Q4 2025.
EBR Systems (EBRCZ) EBITDA Margin (2025 - 2026) Analysis & Trends
EBR Systems has reported EBITDA Margin for 2 years, with the latest figure at 684.67% in Q1 2026.
- Quarterly EBITDA Margin changed N/A year-over-year to 684.67% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1318.86% (changed N/A YoY) and the FY2025 annual result came in at 2850.15%, changed N/A from the prior year.
- EBITDA Margin rose to 684.67% in Q1 2026 per EBRCZ's latest filing, from 1421.36% in the prior quarter.
- Over five years, EBITDA Margin peaked at 684.67% in Q1 2026 and troughed at 6559.62% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 19.15% |
| 10 | EBR Systems | 11.82 Mn | 11.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -684.67% |
| Dec 31, 2025 | -1,421.36% |
| Sep 30, 2025 | -2,320.05% |
| Jun 30, 2025 | -6,559.62% |